Irreversiblae pulpitis. Diseases of pulp and periapical tissues
Conditions
Interventions
Intervention 1: intervention group (Dexamethasone)
0.5 mg 30 min before injection. Intervention 2: intervention groups (Ibuprofen )
400 mg 30 min before injection. Intervention 3: control group (pl
Treatment - Drugs
Placebo
intervention group (Dexamethasone)
0.5 mg 30 min before injection
intervention groups (Ibuprofen )
400 mg 30 min before injection
control group (placebo: Lactose) 30 min before injection
Sponsors
Periodontal and dental research center
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: healthy patients having a first or second mandibular molar tooth with irreversible pulpitis and normal periapical radiographic appearance. Exclusion criteria: the presence of systemic disorders, a sensitivity to lidocaine with 1:80,000 epinephrine; a sensitivity to NSAIDs; nasal polyp; a history of gastrointestinal ulcers; the presence of widening of the periodontal ligament space; the presence of a periapical radiolucency; lactation, pregnancy; using any type of analgesic medication in the preceding 12 hours before the treatment; having a tooth not suitable for restoration, and having a full crown.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inferior alveolar nerve block. Timepoint: 45 minute after intervention (15 minute after injection). Method of measurement: visual analoge scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Analgesia during access cavity preparation and entrance into the root canal. Timepoint: during access cavity preparation and entrance into the root canal. Method of measurement: visual analoge scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactProf. Shahriar Shahi
Faculty of Dentistry
Outcome results
None listed